UVE (2024 - Q2)

Release Date: Jul 26, 2024

...

Stock Data provided by Financial Modeling Prep

Surprises

Adjusted Diluted EPS Beat

+35.6%

$1.18

Adjusted diluted earnings per common share was $1.18, up from $0.87 in the prior year quarter.

Core Revenue Growth

+12.5%

$379.2 million

Core revenue of $379.2 million, was up 12.5% year-over-year with growth primarily stemming from higher net premiums earned and net investment income.

Direct Premiums Written Growth

+5.7%

$578.3 million

Direct premiums written were $578.3 million, up 5.7% from the prior year quarter, including 0.9% growth in Florida and 30.1% growth in other states.

Net Premiums Earned Growth

+13.7%

$345 million

Net premiums earned were $345 million, up 13.7% from the prior year quarter.

Net Combined Ratio Improvement

95.9%

The net combined ratio was 95.9%, down 3.2 points compared to the prior year quarter.

Net Loss Ratio Improvement

70.6%

The 70.6% net loss ratio was down 3.2 points compared to the prior year quarter.

Impact Quotes

We continue to see the positive impacts of the legislation from December '22, and it continues to flow through, primarily relative to represented and litigation affecting our book.

We delivered a solid 30.5% annualized adjusted return on common equity and 35.6% adjusted diluted earnings per share growth year-over-year.

Adjusted diluted earnings per common share was $1.18, up from $0.87 in the prior year quarter, mostly stemming from higher underwriting and net investment income.

Despite having substantially more demand for private market reinsurance, the overall cost of our program was only up modestly.

We are really focused on rate adequacy and our relationship with our agency force has proven to be stellar.

The net combined ratio was 95.9%, down 3.2 points compared to the prior year quarter, reflecting a lower net loss ratio.

We have a high degree of confidence in our ability going forward relative to the market and where we'll be positioned.

During the second quarter, the company repurchased approximately 274,000 shares at an aggregate cost of $5.3 million.

Key Insights:

  • Adjusted diluted earnings per common share was $1.18, up from $0.87 in the prior year quarter.
  • Core revenue was $379.2 million, up 12.5% year-over-year, driven by higher net premiums earned and net investment income.
  • Direct premiums written were $578.3 million, up 5.7% year-over-year, including 0.9% growth in Florida and 30.1% growth in other states.
  • Net premiums earned were $345 million, up 13.7% year-over-year, due to higher direct premiums earned and a lower ceded premium ratio.
  • The company delivered a 30.5% annualized adjusted return on common equity and 35.6% adjusted diluted earnings per share growth year-over-year.
  • The net combined ratio was 95.9%, down 3.2 points from the prior year quarter, reflecting a lower net loss ratio of 70.6%.
  • The net expense ratio was 25.3%, unchanged from the prior year quarter.
  • Management is currently analyzing rates for 2024 with actuaries to assess the impact of tort reform on pricing.
  • The company is confident in its market position and agency relationships to maintain competitive advantage going forward.
  • The company is optimistic about the positive impacts of Florida tort reform and expects continued benefits to underwriting results.
  • There is no current pressure from regulators or competitors to reduce rates, and the company remains focused on rate adequacy.
  • A quarterly cash dividend of $0.16 per share was declared, payable in August 2024.
  • Despite increased demand for private market reinsurance following the expiration of certain layers, the overall cost of the reinsurance program increased only modestly.
  • Florida policies in force increased sequentially for the second quarter in a row and overall policies in force increased year-over-year for the first time since 2021.
  • The company completed the placement of its 2024-2025 reinsurance renewal with strong support from existing and new partners.
  • The company repurchased approximately 274,000 shares at a cost of $5.3 million during the quarter, with $14.7 million remaining in the share repurchase authorization.
  • CEO Steve Donaghy expressed optimism about the positive impacts of Florida tort reform and the company’s strong underwriting performance.
  • Management highlighted the importance of rate adequacy and strong agency relationships in maintaining competitive positioning.
  • The company is cautiously optimistic but increasingly confident about future claims and litigation trends.
  • The leadership emphasized the successful renewal of reinsurance programs and prudent capital management through share repurchases and dividends.
  • Catastrophe losses were well contained within loss expectations despite typical weather events.
  • Management confirmed continued positive impacts from Florida tort reform legislation enacted in December 2022.
  • Management does not currently see regulatory or competitive pressure to reduce rates and is focused on maintaining rate adequacy.
  • Management remains confident in its market position and agency force despite potential competitive dynamics.
  • The company is analyzing the impact of tort reform on 2024 rates with actuaries and expects to adjust pricing accordingly.
  • There was no reserve development in the quarter, indicating stable claims assumptions.
  • The Board declared a quarterly cash dividend of $0.16 per share payable in August 2024.
  • The call included a reminder about forward-looking statements and non-GAAP financial measures with references to the company’s website and SEC filings for more information.
  • The company’s share repurchase program remains active with $14.7 million available for future repurchases.
  • Management’s cautious optimism reflects a balance of positive legislative impacts and ongoing market monitoring.
  • The company’s strong agency relationships are a competitive advantage in rate setting and market positioning.
  • The company’s underwriting performance and claims trends are key drivers of earnings growth.
  • The reinsurance renewal was successfully completed despite a challenging market environment with increased demand for private market reinsurance.
Complete Transcript:
UVE:2024 - Q2
Operator:
Good morning, ladies and gentlemen, and welcome to Universal Second Quarter 2024 Earnings Conference Call. As a reminder, this conference call is being recorded. I would now like to turn the conference over to Arash Soleimani, Chief Strategy Officer. Arash So
Arash Soleimani:
Good morning. Thank you for joining us today. Welcome to our quarterly earnings call. On the call with me today are Steve Donaghy, Chief Executive Officer; and Frank Wilcox, Chief Financial Officer. Before we begin, please note today's discussion may contain forward-looking statements and non-GAAP financial measures. Forward-looking statements involve assumptions, risks and uncertainties that could cause actual results to differ materially from those statements. For more information, please see the press release and Universal's SEC filings, all of which are available on the Investors section of our website at universalinsuranceholdings.com and on the SEC's website. A reconciliation of non-GAAP financial measures to comparable GAAP measures is included in the quarterly press release and can also be found on Universal's website at universalinsuranceholdings.com. With that, I'll turn the call over to Steve.
Stephen Donaghy:
Thank you, Arash. Good morning, everyone. In the quarter, we delivered a solid 30.5% annualized adjusted return on common equity and 35.6% adjusted diluted earnings per share growth year-over-year. Results were driven by strong underwriting performance, and we continue to see encouraging claims and litigation trends. Florida policies in force increased sequentially for the second quarter in a row and overall policies in force increased year-over-year for the first time since 2021. As we mentioned previously, we completed the placement of our 2024-2025 reinsurance renewal for our insurance entities. We're very pleased with the outcome of the program and the support we received from our long-standing reinsurance partners and from new partners as well. Importantly, despite having substantially more demand for private market reinsurance, following the expirations of the Reinsurance to Assist Policyholders layer and our catastrophe bond, the overall cost of our program was only up modestly. I'll turn it over to Frank to walk through our financial results. Frank?
Frank Wilcox:
Thanks, Steve. Good morning. Adjusted diluted earnings per common share was $1.18, up from $0.87 in the prior year quarter. The increase mostly stems from higher underwriting and net investment income. Core revenue of $379.2 million, was up 12.5% year-over-year with growth primarily stemming from higher net premiums earned and net investment income, partially offset by lower commission revenue. Direct premiums written were $578.3 million, up 5.7% from the prior year quarter, including 0.9% growth in Florida and 30.1% growth in other states. Overall growth mostly reflects higher rates, inflation adjustments and higher policies in force. Direct premiums earned were $490.6 million, up 5.9% from the prior year quarter, reflecting direct premiums written growth over the last 12 months. Net premiums earned were $345 million, up 13.7% from the prior year quarter. The increase is primarily attributable to higher direct premiums earned and a lower ceded premium ratio. The net combined ratio was 95.9%, down 3.2 points compared to the prior year quarter. The decrease reflects a lower net loss ratio. The 70.6% net loss ratio was down 3.2 points compared to the prior year quarter, with the decrease primarily attributable to higher net premiums earned associated with lower reinsurance costs in the current year quarter and a lack of reserve development in the current year quarter. The net expense ratio was 25.3%, unchanged from the prior year quarter. During the second quarter, the company repurchased approximately 274,000 shares at an aggregate cost of $5.3 million. The company's current share repurchase authorization program has approximately $14.7 million remaining. On July 11, 2024, the Board of Directors declared a quarterly cash dividend of $0.16 per share of common stock payable on August 9, 2024 to shareholders of record as of the close of business on August 2, 2024. With that, I'd like to ask the operator to open the line for questions.
Operator:
Thank you. [Operator Instructions] And our first question comes from Paul Newsome with Piper Sandler. Your line is open.
Paul Newsome:
Good morning. Thanks for the call. Congrats on the quarter. I was going to ask sort of any updated thoughts on the impact of tort reform in Florida? And I've got just other -- just miscellaneous questions to ask.
Stephen Donaghy:
Hey, Paul. Good morning. This is Steve Donaghy. Yeah. We continue to see the positive impacts of the legislation from December '22, and it continues to flow through, primarily relative to represented and litigation affecting our book. So continue to see positive impacts, obviously turned from cautiously optimistic to optimistic a while back, and we continue to see positive outlooks, which really leads us to be very positive on our share repurchases and happy with the position we're in right now.
Paul Newsome:
Great. Were there any movement in the reserves development wise in the quarter?
Frank Wilcox:
We had zero -- good morning, Paul. This is Frank. So no, we had zero net development this quarter on reserves.
Paul Newsome:
Okay. What about like the catastrophe losses, and I think in the past, you've talked about weather above plan. It looks like it was knock on wood, pretty good weather quarter, all things even.
Frank Wilcox:
Yeah. Sure. I mean we have weather every quarter, but it was well contained within our loss pick.
Paul Newsome:
Great. So back to the tort reform question, some questions about whether or not the industry is going to push back, and we're going to get a fairly quick level of competition coming in with filed rate declines. Is that something that we should be watching? Any thoughts on maybe, if the regulators are asking for lower rates at this point given the tort reform?
Stephen Donaghy:
Paul, it's an interesting question. We're not getting any pressure from anyone relative to rates or anything else. We are currently in the midst of analyzing our rates with our actuaries and external actuaries on what the impact will be to 2024. We do see the impacts of the tort reform, clearly, are we're seeing -- expecting a reduction in what is supposed to be passed along. And then, we'll weigh that as we always have with how we see the market as we take rate going forward, but again, we're optimistic. And the hope is that the market will continue to be successful. But as a company, we don't worry a tremendous amount about the competition. We are really focused on rate adequacy and our relationship with our agency force has proven to be stellar. So we have a high degree of confidence in our ability going forward relative to the market and where we'll be positioned.
Paul Newsome:
Great. Appreciate the help, as always and congratulations on the quarter.
Stephen Donaghy:
Thanks, Paul. Have a good day.
Operator:
Thank you. There are no further questions at this time. I'd like to turn the call back over to Steve Donaghy for any closing remarks.
Stephen Donaghy:
Thank you. I'd like to thank all of our associates, consumers, our agency force and our stakeholders for their continued support of Universal. Have a great day.
Operator:
Thank you for your participation. This does conclude the program. You may now disconnect. Everyone, have a great day.

Here's what you can ask